{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T22:22:10Z","timestamp":1770070930935,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.healun.2004.03.025","type":"journal-article","created":{"date-parts":[[2005,5,10]],"date-time":"2005-05-10T17:49:35Z","timestamp":1115747375000},"page":"703-707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Is Bridging to Transplantation With a Left Ventricular Assist Device a Risk Factor for Transplant Coronary Artery Disease?"],"prefix":"10.1016","volume":"24","author":[{"given":"Branislav","family":"Radovancevic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Golino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bojan","family":"Vrtovec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia D.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajko","family":"Radovancevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peggy","family":"Odegaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles C.","family":"van Rossem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiaan J.M.","family":"Gaemers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William K.","family":"Vaughn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank W.","family":"Smart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.H.","family":"Frazier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2004.03.025_bib1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1053-2498(98)00006-0","article-title":"Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization","volume":"18","author":"Stringham","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2004.03.025_bib2","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0003-4975(97)00807-2","article-title":"Factors influencing HLA sensitization in implantable LVAD recipients","volume":"64","author":"Massad","year":"1997","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2004.03.025_bib3","doi-asserted-by":"crossref","first-page":"II229","DOI":"10.1161\/circ.100.suppl_2.Ii-229","article-title":"Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients","volume":"100","author":"John","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2004.03.025_bib4","first-page":"876","article-title":"Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support","volume":"17","author":"Moazami","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2004.03.025_bib5","first-page":"272","article-title":"Tissue typing, heart and heart-lung transplantation","volume":"50","author":"Joysey","year":"1993","journal-title":"Br J Biomed Sci"},{"key":"10.1016\/j.healun.2004.03.025_bib6","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0022-5223(96)70141-1","article-title":"Does successful bridging with the implantable left ventricular assist device affect cardiac transplantation outcome?","volume":"112","author":"Massad","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2004.03.025_bib7","first-page":"II294","article-title":"Pretransplant panel reactive-antibody screens","volume":"94","author":"Kobashigawa","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2004.03.025_bib8","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1161\/01.CIR.98.8.786","article-title":"Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation","volume":"98","author":"Itescu","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2004.03.025_bib9","first-page":"S120","article-title":"Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients","volume":"11","author":"Rose","year":"1992","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2004.03.025_bib10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00007890-198504000-00009","article-title":"Heart graft arteriosclerosis","volume":"39","author":"Palmer","year":"1985","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2004.03.025_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/ajcp\/69.2.103","article-title":"Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture","volume":"69","author":"Terasaki","year":"1978","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.healun.2004.03.025_bib12","first-page":"1093","article-title":"Clinical heart transplantation without routine endomyocardial biopsy","volume":"11","author":"Warnecke","year":"1992","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2004.03.025_bib13","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/0002-9149(88)90885-5","article-title":"Retransplantation for severe accelerated coronary artery disease in heart transplant recipients","volume":"62","author":"Gao","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2004.03.025_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0041-1345(00)00862-9","article-title":"Neoral use in the cardiac transplant recipient","volume":"32","author":"Valantine","year":"2000","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2004.03.025_bib15","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.CIR.76.4.827","article-title":"Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone","volume":"76","author":"Uretsky","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2004.03.025_bib16","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/00001573-200011000-00009","article-title":"Cardiac allograft vasculopathy","volume":"15","author":"Behrendt","year":"2000","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.healun.2004.03.025_bib17","first-page":"970","article-title":"Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome","volume":"39","author":"Yamani","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2004.03.025_bib18","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1378\/chest.118.6.1792","article-title":"Cardiac transplant vasculopathy","volume":"118","author":"Aranda","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.healun.2004.03.025_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1034\/j.1399-3062.1999.010205.x","article-title":"Cytomegalovirus infection and cardiac allograft vasculopathy","volume":"1","author":"Koskinen","year":"1999","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.healun.2004.03.025_bib20","first-page":"S14","article-title":"Cytomegalovirus and other herpesviruses","volume":"11","author":"Kendall","year":"1992","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2004.03.025_bib21","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/S0003-4975(00)01083-3","article-title":"Effects of left ventricular assist devices on outcomes in patients undergoing heart transplantation","volume":"69","author":"Bank","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2004.03.025_bib22","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S1053-2498(01)00232-7","article-title":"Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation","volume":"20","author":"Pagani","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2004.03.025_bib23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1053-2498(00)00246-1","article-title":"Cardiac transplant outcome of patients supported on left ventricular assist device vs. intravenous inotropic therapy","volume":"20","author":"Jaski","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2004.03.025_bib24","first-page":"744","article-title":"Heart transplant coronary artery disease detected by coronary angiography","volume":"17","author":"Costanzo","year":"1998","journal-title":"J Heart Lung Transplant"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249804002177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249804002177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:10:51Z","timestamp":1760947851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249804002177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S1053249804002177"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2004.03.025","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is Bridging to Transplantation With a Left Ventricular Assist Device a Risk Factor for Transplant Coronary Artery Disease?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2004.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}